Initial Results of a Phase 1 Dose Escalation Study of LP-168, a Novel Covalent and Non-Covalent Next-Generation Inhibitor of Bruton's Tyrosine KinaseJennifer A. Woyach,Deborah M. Stephens, Danielle M Brander,Adam S Kittai,Boyu Hu, Andrea Sitlinger,Emily K Curran,Fenlai Tan,Yi Chen, Stephen P. Anthony,Yu Chen,John C. ByrdBlood(2023)引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要